Release Summary

Acetylon will present clinical data on the use of HDAC6 inhibitors Ricolinostat (ACY-1215) and ACY-241 in combination with pomalidomide for the treatment of multiple myeloma at the ASH Annual Meeting.

Acetylon Pharmaceuticals, Inc.